22 New Featured FDA 483s | August 9, 2016

Here are the featured FDA 483s for the week. You can obtain these at the FDAzilla 483s store here>>

Inspection End Date Company City/Local State/Region Country
9/17/2015 American Dent-all Inc Glendale CA United States
9/10/2015 Bedfont Scientific, Ltd. Maidstone United Kingdom
9/17/2015 Biomatlante Vigneux De Bretagne France
11/13/2015 Boehringer Ingelheim Pharma Gmbh & Co Kg Biberach An Der Ris Germany
11/9/2015 DDC Technologies Inc Oceanside NY United States
10/23/2015 Farmabios, S.p.A. Gropello Cairoli Italy
10/24/2014 Fresenius Kabi USA, LLC Grand Island NY United States
12/3/2015 G S Cosmeceutical USA Inc Livermore CA United States
3/17/2015 Gland Pharma Limited Ranga Reddy, Hyderabad India
12/9/2015 Invacare Corporation Elyria OH United States
9/18/2015 IVD Research, Inc. Carlsbad CA United States
9/5/2014 Larson, Richard A., M.D. Chicago IL United States
7/1/2011 Merck Serono S.p.A. Guidonia Montecelio Italy
11/12/2013 Merck Serono SA Aubonne Aubonne Switzerland
6/16/2011 Merck Serono SA Aubonne Aubonne Switzerland
12/4/2015 Myriad Genetics Laboratories, Inc. Salt Lake City UT United States
11/6/2015 Novo Nordisk A/S Kalundborg Denmark
9/11/2015 Oculo-Plastik, Inc. Montreal Canada
7/22/2015 Pacira Pharmaceuticals, Inc. San Diego CA United States
1/15/2016 Respironics California Inc Carlsbad CA United States
8/10/2015 Sanofi Pasteur Limited – Cannaught Campus North York Canada
1/29/2016 Teva Pharmaceutical Works Co. Ltd. Godollo Hungary

Learn more about how FDAzilla can help you achieve your quality and inspection preparation goals: get 483sInspector ProfilesEnforcement Analytics, and GMP Regulatory Intelligence. Contact me if you ever have questions at tony@fdazilla.com.

Leave a Reply

Your email address will not be published. Required fields are marked *